These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 429282)

  • 1. Intestinal and pancreatic glucagon-like peptides. Evidence for identity of higher molecular weight forms.
    Tager HS; Markese J
    J Biol Chem; 1979 Apr; 254(7):2229-33. PubMed ID: 429282
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.
    Orskov C; Holst JJ; Knuhtsen S; Baldissera FG; Poulsen SS; Nielsen OV
    Endocrinology; 1986 Oct; 119(4):1467-75. PubMed ID: 3530719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic and intestinal processing of proglucagon in man.
    Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
    Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
    Larsson LI; Moody AJ
    J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.
    Itoh H; Namba M; Watanabe N; Ohara T; Matsuyama T; Komatsu R; Shinomura Y; Kono N; Tarui S
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1010-7. PubMed ID: 2610678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of pancreatic glucagon at the picogram level using beta-D-galactosidase as a label.
    Iwasa S; Ueno H; Miya T; Wakismasu M; Kondo K; Ohneda A
    J Biochem; 1979 Oct; 86(4):943-9. PubMed ID: 115858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.
    Mojsov S; Kopczynski MG; Habener JF
    J Biol Chem; 1990 May; 265(14):8001-8. PubMed ID: 1692320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas.
    Tateishi K; Shima K; Funakoshi A; Yasunami Y; Iwamoto N; Matsuoka Y
    Diabetes Res Clin Pract; 1994 Aug; 25(1):43-9. PubMed ID: 7835211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
    Vaillant CR; Lund PK
    J Histochem Cytochem; 1986 Sep; 34(9):1117-21. PubMed ID: 3755450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas.
    Thim L; Moody AJ
    Biochim Biophys Acta; 1982 May; 703(2):134-41. PubMed ID: 7082677
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin releasing activity of gastrointestinal glucagon-like immunoreactive materials in perfused rat pancreas.
    Tanaka R; Matsuyama T; Shima K; Sawazaki N; Tarui S; Kumahara Y
    Endocrinol Jpn; 1977 Dec; 24(6):575-9. PubMed ID: 606546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino acid sequence of radioimmunoassayable neurotensin from bovine intestine.
    Carraway R; Kitabgi P; Leeman SE
    J Biol Chem; 1978 Nov; 253(22):7996-8. PubMed ID: 711731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primary structure of porcine glicentin (proglucagon).
    Thim L; Moody AJ
    Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a porcine intestinal peptide with C-terminal somatostatin.
    Pradayrol L; Chayvialle JA; Carlquist M; Mutt V
    Biochem Biophys Res Commun; 1978 Nov; 85(2):701-8. PubMed ID: 736928
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon- and glicentin-immunoreactive cells in the human digestive tract.
    Garaud JC; Eloy R; Moody AJ; Stock C; Grenier JF
    Cell Tissue Res; 1980; 213(1):121-36. PubMed ID: 7006827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structures of glucagon and glucagon-like peptide from catfish pancreas.
    Andrews PC; Ronner P
    J Biol Chem; 1985 Apr; 260(7):3910-4. PubMed ID: 3838546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion.
    Tatemoto K
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2514-8. PubMed ID: 6953409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.